Victor Oginga Oria

Victor Oginga Oria, PhD, is an Assistant Professor at the Biotech Research and Innovation Centre (BRIC) within the University of Copenhagen, where he leads research in cancer biology as part of the Erler Group. His current position began in 2024 following his Marie Curie Co-Fund LEADer Postdoc Fellowship at the same institution (2022-2024). Prior to this, he held postdoctoral positions at Yale Cancer Center (2019-2021) and BRIC's Kveiborg Group (2021-2022).

Education includes:

• Ph.D. in Molecular Medicine (University of Freiburg, 2018)
• MSc in Medical Diagnostics (Cranfield University, 2014)
• BSc in Biochemistry (Kenyatta University, 2011)

Dr. Oria's research focuses on tumor progression mechanisms with emphasis on:

• Cancer metastasis and tumor vasculature dynamics including angiogenesis, vascular mimicry, and angiocrine signaling
• Identification of novel biomarkers and therapeutic targets across multiple cancer types
• Translational approaches bridging basic science with clinical applications
• Science communication and leadership development in academia

His work employs molecular biology techniques, preclinical models, and clinical data analysis to investigate tumor microenvironment interactions.

Recent publications (15 total outputs) demonstrate a consistent focus on tumor microenvironment modulation, metastasis mechanisms, and therapeutic innovation. Key trends include investigations into vascular mimicry in melanoma brain metastasis (2024), radiation-induced biomarker expression in rectal cancer (2023), and combination immunotherapies (2023). Articles frequently integrate molecular biology with clinical oncology, highlighting translational relevance.

Awards & Honors:

• Marie Curie Co-Fund LEADer Postdoc Fellowship (2022-2024)

Dr. Oria collaborates extensively within international research networks as evidenced by multi-institutional publications. He currently leads projects within the Erler Group at BRIC, investigating tumor vasculature signaling pathways and their therapeutic implications.